Advanced prostate cancer can be treated with androgen deprivation therapy (ADT),2 which can include a surgical or chemical castration using the luteinizing hormone receptor agonist leuprolide and demonstrates that the disease has a reliance on androgen receptor (AR) signaling (2). Here, AR is linked to prostate cancer.